Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease

NCT07483372 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Resistant Arterial Hypertension
Chronic Kidney Disease (Stage 3-4)

Interventions

DRUG: SC101

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]